Company Valuation: ABL Diagnostics

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 2.96 3.988 29 156.3 39.64 48.34
Change - 34.75% 627.14% 439.03% -74.64% 21.95%
Enterprise Value (EV) 1 0.6006 1.286 30.64 157.5 41.66 49.27
Change - 114.05% 2,283.25% 414.19% -73.55% 18.27%
P/E -33.1x 15.5x 206x 2,876x 123x 50x
PBR 1.25x 1.52x 34.5x 23.1x 5.29x 6.32x
PEG - -0x -4.5x -30.2x 0x 0x
Capitalization / Revenue - 221,548,833,333x 3,097,618x 25,256,446x 6,753,666x 6,068,760x
EV / Revenue - - - - - -
EV / EBITDA - - - - - -
EV / EBIT -6.59x -12.5x 517x -240x -85x 155x
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - 0.05 0.11
Rate of return - - - - 2.03% 3.67%
EPS 2 -0.0445 0.1285 0.07 0.003373 0.02 0.06
Distribution rate - - - - 250% 183%
Net sales - 0.000018 9.361 6.189 5.869 7.966
EBITDA - - 0.62 0.005134 0.2459 0.4283
EBIT 1 -0.0912 -0.1026 0.0593 -0.6571 -0.4904 0.3171
Net income 1 -0.0893 0.2579 1.106 0.0544 0.2852 0.9867
Net Debt 1 -2.359 -2.702 1.643 1.244 2.024 0.9326
Reference price 2 1.475 1.988 14.452 9.700 2.460 3.000
Nbr of stocks (in thousands) 2,006 2,006 2,006 16,114 16,114 16,114
Announcement Date 23/04/21 20/05/22 01/08/23 31/07/24 06/05/25 07/05/26
1EUR in Million2EUR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 43.59M
31.69x4.28x16.43x2.33% 191B
19.8x3.57x12.75x3.17% 118B
18.42x0.21x13.39x0.71% 64.19B
29.93x7.38x19.05x1.33% 51.49B
36.14x3.47x11.9x2.09% 51.08B
35.95x6.33x19.86x-.--% 33.85B
46.86x1.34x12.44x0.2% 31.85B
39.96x7x25.11x0.26% 24.11B
18.71x2.93x10.5x1.5% 22.96B
Average 30.83x 4.06x 15.71x 1.29% 58.87B
Weighted average by Cap. 28.99x 3.91x 15.30x 1.85%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. ABLD Stock
  4. Valuation ABL Diagnostics